Allakos Secures $10,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    75 Shoreway Road San Carlos, CA 94070 USA
  • Company Description
    Allakos Inc. is a privately held, product-focused biotechnology company developing first-in-class antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 (Th2) immune response plays a key role in pathology, including allergic disease, inflammation and diseases characterized by excess production of inflammatory cells.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The additional funding will enable us to advance two programs towards meaningful near-term milestones.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy